CSRXP SENATE BATTLEGROUND POLL: VOTERS BACK GRASSLEY-WYDEN, DEMAND ACTION TO HOLD BIG PHARMA ACCOUNTABLE

Survey Finds Overwhelming Majorities of Swing State Voters Blame Drug Makers for Rising Prices and Want Congress to Pass Bipartisan Reforms Before Year End

For Immediate Release
Contact: Jon Conradi
860-235-3884
[email protected]

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday on a new survey conducted in five top 2020 Senate battleground states that found an overwhelming majority of voters hold Big Pharma responsible for out-of-control prescription drug prices and want Congress to pass bipartisan reforms before the end of the year. The survey, commissioned by CSRxP and conducted by Morning Consult, surveyed voters in Arizona, Colorado, Georgia, Iowa and Maine.

“Voters in key Senate battlegrounds are demanding urgent action from their elected leaders in Congress to hold Big Pharma accountable and lower prescription drug prices,” said CSRxP executive director Lauren Aronson. “There is overwhelming support, across every ideological and party affiliation, for bipartisan solutions that will disincentivize Big Pharma’s price-gouging, keep price hikes below the rate of inflation, cap out-of-pocket costs for seniors, increase competition and boost transparency.”

“Voters rightly hold Big Pharma accountable for the out-of-control prices of prescription drugs,” Aronson continued. “They are watching closely to see if their elected leaders summon the political courage to deliver results for American patients by backing reforms to hold drug makers accountable and lower prices before year end.”

Key takeaways from the CSRxP Senate Battleground Survey include:

A Decisive Majority of Voters Hold Big Pharma Responsible for Out-of-Control Prices

Voters Overwhelmingly Agree Drug Prices are a Top Priority Issue
Massive Majorities Support Grassley-Wyden and Want the Senate to Pass Those Reforms
Voters Want Congress to Pass Bipartisan Reforms Now, Before Year End
Morning Consult’s summary of the survey can be found HERE.

Read more on the unprecedented momentum for drug pricing action in Congress and measures with significant bipartisan support HERE.

###

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.